REQUEST A DEMO
Total
USD $0.00
Search more companies

Shinsung Pharm Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Shinsung Pharm Co.,Ltd. Profile Updated: October 23, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Shinsung Pharm Co.,Ltd. is engaged in distribution of medicines and medical supplies. The company also offers sole distributorship, as well as purchasing and logistics services including GPO and logistics services in hospital, agency service for distributing medical goods, hospital open & management consulting, among others. Shinsung Pharm Co.,Ltd. is based in Seoul with an operational logistics center in Gimpo, Gyeonggi-do Province, South Korea. The company was established in 1985.

Headquarters
35-19, Arayuk-ro 58beon-gil Gochon-eup Gimpo-si Gyeonggi
Gimpo; Gyeonggi;

Contact Details: Purchase the Shinsung Pharm Co.,Ltd. report to view the information.

Website: http://www.e-shinsung.co.kr

Basic Information
Total Employees:
Purchase the Shinsung Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Shinsung Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Shinsung Pharm Co.,Ltd. report to view the information.
Incorporation Date:
September 10, 1985
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
64%
Purchase this report to view the information.
36.1%
Subsidiaries
E&S Care Co.,Ltd.
66.2%
Company Performance
Financial values in the chart are available after Shinsung Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-0.3%
Total operating revenue
-0.3%
Operating profit (EBIT)
23.01%
EBITDA
20.24%
Net Profit (Loss) for the Period
-24.58%
Total assets
4.87%
Total equity
-5.97%
Operating Profit Margin (ROS)
0.23%
Net Profit Margin
-0.06%
Return on Equity (ROE)
-0.69%
Debt to Equity Ratio
27.55%
Quick Ratio
-0.03%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?